RecruitingNot ApplicableNCT06992011

A Randomized Controlled Trial Comparing Clinical Effectiveness of SMILE Versus SMILE Xtra in Myopia


Sponsor

Shanghai Zhongshan Hospital

Enrollment

300 participants

Start Date

Feb 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

To evaluate and compare the clinical efficacy, biomechanical stability, and optical quality of SMILE and SMILE Xtra procedures in patients with myopia through a randomized controlled trial


Eligibility

Min Age: 18 YearsMax Age: 50 Years

Inclusion Criteria6

  • Age 18-50 years
  • MRSE (Manifest Refraction Spherical Equivalent) -6.00D to -10.00D with refractive changes within ±0.50D in past 2 years
  • CDVA (Corrected Distance Visual Acuity) ≥ 20/25
  • Myopia progression ≤ 0.50D/year for ≥2 years
  • RST (Residual Stromal Thickness) ≥ 250μm after lenticule removal
  • Contact lens discontinuation as per protocol

Exclusion Criteria6

  • Other eye diseases (keratoconus, glaucoma, etc.)
  • Corneal scarring, cataracts affecting observation
  • Systemic diseases affecting surgery compliance
  • Prior ocular surgeries
  • Pregnancy, breastfeeding, or menstruation
  • Drug allergies to surgical medication

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURESMILE

Small Incision Lenticule Extraction

PROCEDURESMILE Xtra

Small Incision Lenticule Extraction combined with Corneal Cross-linking (SMILE Xtra)


Locations(1)

Zhongshan Hospital

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06992011


Related Trials